Hepatobiliary Disease Platform
The hepatobiliary system (comprised of the liver, gallbladder, and bile ducts) plays an important role in digestion and in the biotransformation and disposition of endogenous molecules and drugs. Hepatobiliary diseases range from minor infection or scarring to serious conditions such as cancer. At this year’s EASL conference, WuXi AppTec showcased our comprehensive platform of hepatobiliary-related services, such as our CAP-certified pathology laboratory and our extensive panel of animal disease models, including NAFLD, fibrosis, cirrhosis, and a clinically relevant NASH mouse model.
Hepatobiliary Disease Platform
- All-encompassing hepatobiliary disease models:
- NAFLD, NASH, Fibrosis, Cirrhosis, PBC/PSC, ALD, and more
- Comprehensive hepatic tissue bank and transcriptomics database
- Professional quantitative analysis in pathology
Histopathology Laboratory
- CAP-certified pathology laboratory
- Tissue processor
- Embedding center
- Cyostats
- Microtomes
- Staining workstation
- IHC & ISH stainer
- Laser-scanning confocal microscope
- HALO-AI quantitative histopathology

Hepatobiliary_Disease Platform
Related Content
Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is a serious liver disease. If left untreated, MASH can...
VIEW RESOURCEIntroduction: OncoWuXi Express will continue to keep you informed about updates to our online pharmacology model database (OncoWuXi Database), as...
VIEW RESOURCE